Aspire Biopharma Holdings, Inc. 8-K

What Happened
Aspire Biopharma Holdings, Inc. (ASBP) filed an 8-K on June 12, 2026 to report that it adjourned its previously scheduled shareholder meeting and rescheduled the meeting for June 16, 2026 at 10:00 a.m. Eastern Standard Time. The company confirmed the adjourned meeting will use the same online meeting link: www.colonialstock.com/AspireBiopharma2026.

Key Details

• Filing date: June 12, 2026 (Form 8-K).
• New meeting date and time: June 16, 2026 at 10:00 a.m. EST.
• Meeting access: unchanged — www.colonialstock.com/AspireBiopharma2026.
• Item reported on the Form 8-K: Item 8.01 (Other Events).

Why It Matters
For investors and shareholders planning to attend or vote, the adjournment changes the timing for any live participation or final voting on proposals. The notice confirms the meeting is still being held electronically and provides the URL to access the adjourned session; shareholders should use that link for attendance and any meeting materials.